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Executive Summary
BACKGROUND
In Kenya, the maternal mortality ratio remains high at 488 deaths per 100,000 live births with 35 per cent of
these deaths arising from unsafe abortion. Public debate on abortion and on proposals to liberalize the abortion
law has been on-going for several years in the country. With the passing of a new Constitution in 2010, there
was renewed interest in the right to health and the need to reduce the high levels of maternal morbidity and
mortality arising from unsafe abortion in the country. In 2012, for instance, the Government issued Standards
and Guidelines for Reducing Morbidity and Maternal from Unsafe Abortion that emphasized professional nonjudgmental counseling and provision of safe options in cases of unplanned, risky or unwanted pregnancies in
line with the Constitution. The Constitution, on the other hand, stipulates that abortion is permissible if in the
opinion of a trained health professional, there is need for emergency treatment, or the life or health of the mother
is in danger or as determined by any other law. Apart from the legal and policy discourses, medical abortion using
a combination treatment of Mifepristone and Misoprostol has been classified by WHO as a safe and effective
method to stop a pregnancy up to 9 completed weeks since the last menstrual period i.e. during the first
trimester. The two drugs are registered in Kenya for various indications, including treatment of

incomplete abortion and miscarriage, treatment and prevention of post-partum haemorrhage (PPH),
treatment of intrauterine foetal death, cervical ripening, and as a uterotonic drug to induce or increase
uterine contractions. In spite of the developments, there is limited understanding of the extent to which the
changes have influenced the provision of medical abortion information and services in the country, the
acceptability of the practice among providers and clients, and the content of care offered.

OBJECTIVES
The overall goal of the study was to generate evidence on the availability, use and quality of care for medical
abortion services in private facilities (pharmacies and clinics) in Kenya. The specific objectives of the study were
to: (1) understand the contextual and programmatic factors that influence or are likely to influence the provision
of medical abortion services in Kenya; (2) explore the perspectives (positive and negative) of various
stakeholders about abortion generally and the provision of medical abortion services specifically; (3) assess the
availability of Mifepristone and Misoprostol or other abortifacient as well as the skills and practices of private
providers; (4) examine the knowledge and attitudes of private providers regarding Mifepristone and Misoprostol
or other abortifacients; (5) determine the characteristics, choices and perceptions of clients seeking abortion
services from private clinics; and (6) explore the information and services given to clients seeking medical
abortion services from private pharmacies and clinics. Private facilities were targeted because access to
information and services on medical abortion in Kenya is mainly through private practitioners while public health
facilities mostly provide post-abortion care services. Private clinics are operated by the cadres of providers that
fall within the legal definition of a health professional including doctors, clinical officers, nurses and midwives
while registered pharmacists and enrolled pharmaceutical technologists are the only cadres of health personnel
qualified to dispense medicines and operate private pharmacies in the country.

METHODS
This was a cross-sectional study that was conducted between April and June 2013 in Nairobi, Kisumu and
Mombasa counties. The study involved: (1) key informant interviews with 19 senior managers from national and
locally-based international institutions representing policy, program, research and donor interests in
reproductive health in general and medical abortion in particular; (2) structured interviews with 235 pharmacy
workers in 235 private pharmacies; (3) 401 simulated client visits to 142 private pharmacies whose workers
participated in the structured interviews; (4) structured interviews with 45 in-charges of private clinics; (5) 141
observations of client-provider interactions during consultations in 32 of the 45 private clinics; and (6) 125 exit
interviews with clients seeking abortion services in the 32 private clinics. The interviews with key informants
were transcribed, typed in Word and analysed for content using NVIVO software. Analysis involved coding of
themes and categorizing the themes within a hierarchical framework of main and sub-themes. Quantitative data
from structured interviews with pharmacy workers, simulated client visits to pharmacies, structured interviews
with facility in-charges, observations of client-provider interactions, and exit interviews with clients were entered
in EpiData and analysed using STATA. Analysis involved simple descriptive statistics including percentages,
means and medians.
vi

KEY FINDINGS
Abortion Environment: Perspectives of Key Informants


Although there has been progress in the legal and policy frameworks regarding abortion to increase the
availability of safe and legal services, many service delivery challenges still persist. Limited dissemination of
relevant documents and lack of clear and officially endorsed policy statements to guide public health
facilities mean that there is a lack of awareness about the revised service standards and guidelines among
service providers and the conditions under which safe abortion services can be legally provided.



Although several non-governmental organizations and professional associations have developed curricula
and supported training of service providers, especially from the private sector, on comprehensive abortion
care, values clarification and attitude transformation and referrals, there is no standard training curriculum
while skills gaps still persist among providers.



Effective delivery of safe legal abortion services are further affected by societal stigma, poor access to
appropriate information especially among those from marginalised settings, inadequate supply of drugs due
to few established distribution channels, poor packaging and storage of relevant drugs, availability of
counterfeits, and price distortion brought about by some of these challenges.

Abortion Services in Private Pharmacies


Very few pharmacy workers (16%) whose outlets provided abortion information or methods had been trained
on the provision of the services with trainings focusing more on ensuring confidentiality and privacy of
clients, history taking, and pain management, and less on the national standards and guidelines, recordkeeping and reporting, criteria for referral procedures and the recommended regimens for the combination
of Mifepristone and Misoprostol.



There was limited stocking of Misoprostol or Mifepristone even in pharmacies that provided abortion
information or methods with only 18% of such pharmacies selling Misoprostol, 2% sold Mifepristone while
none sold the combination of Mifepristone and Misoprostol. In addition, most of the pharmacies did not
have the national standards and guidelines document on reducing maternal mortality and morbidity from
unsafe abortion.



There was limited knowledge of the correct regimen for Misoprostol only (22% of males and 16% of females)
or for combination of Mifepristone and Misoprostol (13% of males and 3% of females) for pregnancies of
various gestational ages among pharmacy workers who knew about the medications.



Although nearly all pharmacy workers (97%) felt that clients seeking Mifepristone and Misoprostol from
pharmacies should have a prescription from a medical practitioner, only 11% indicated having ever denied
clients abortion services because of lack of a prescription while the most common reasons for denial of
services were religious or moral beliefs or lack of a trained provider.



Pharmacy workers performed poorly on all indicators of interactions with simulated clients although the
chances of asking about gestational age (55% of interactions) and advising clients on where to obtain
services for pregnancy termination (50% of interactions) were higher than those of discussing family
planning (12% of interactions), recommending family planning (9% of interactions), offering a method (1%
of interactions), or referring clients elsewhere for family planning (1% of interactions).

Abortion Services in Private Clinics


The most common aspects related to the provision of abortion services that private providers had received
in-service training on were infection prevention (78% of facilities), referral procedures (76% of facilities); and
managing complications (76% of facilities) while the least aspects were the national standards and
guidelines (60% of facilities) and the legal and policy provisions regarding abortion (51% of facilities).



Availability of drugs and supplies for medical abortion was very limited (15% of items) although the
proportion of items that were in stock on the day of interview was similar to what were reported to be
available. By contrast, facilities had most of the drugs and supplies for surgical abortion (81% of items) as
well as for recovery, pain management and treatment of complications (85% of items) although the
vii

proportions of items that were in stock on the day of interview were lower than what was reported to be
available.


Although providers mostly cited health reasons (64% of providers) and preservation of the mother’s life (43%
of providers) as the common legal grounds for induced abortion, about a quarter (23%) noted that induced
abortion can be provided on request, which is contrary to existing laws and regulations. In addition, only
about half (49%) of providers whose facilities stocked Misoprostol mentioned the correct regimen for
pregnancies of various gestational ages.



Two-thirds (66%) of the women seeking abortion services from private clinics were aged between 20 and 29
years, 64% had at least secondary level education, 59% were never married while 56% had a previous
pregnancy, with the majority of those who had more than one pregnancy (86%) reporting having a previous
abortion.



More than half (59%) of clients seeking abortion services had pregnancies of up to 9 weeks with the most
common reason for seeking abortion services being that the pregnancy was unplanned (73%) while other
reasons included the need to continue with education (24%), family pressure (14%), and the need to
continue with employment (14%).



Providers recommended the correct regimen for gestational age in only 31% of consultations in which
medical abortion (Misoprostol alone or combination of Mifepristone and Misoprostol) was recommended.
By contrast, providers recommended manual vacuum aspiration for 54% of pregnancies of up to 9 weeks,
59% of pregnancies above 9 and below 12 weeks, 31% of pregnancies between 12 and 14 weeks, and 58%
of pregnancies over 14 weeks.



Although nearly all (98%) private clinics reported providing family planning information or methods, only 79%
of the clients seeking abortion services were counselled on family planning while 48% were given a method.
Besides, elements of family planning counselling were some of the least performed functions during
consultations (40% of elements performed) while elements of interpersonal relationships such as courteous
handling of clients were some of the most performed by providers (74% of elements performed).



The majority of clients seeking abortion services (78%) had previously used a family planning method, mostly
male condom, oral pills, injectables, and emergency pill. Nearly two-thirds (63%) chose a method on the day
of visit, mostly injectables (40%), male condoms (33%), pills (20%), implants (18%), and IUCDs (18%) while
60% of those who had a previously used a method chose a different method, mostly injectables, IUCD and
implants.



Prices of medical abortion drugs increased with higher gestation age of pregnancy although there were wide
variations in the prices facilities charge for the methods, ranging from KSh. 90 (≈US $1) to KSh. 7,000 (≈US
$82). Prices of surgical abortion methods also varied widely between facilities from KSh. 1,500 (≈US $18)
to KSh. 15,000 (≈US $176).

IMPLICATIONS


There is need for widespread and government-endorsed dissemination of the revised laws, policies,
standards and guidelines on abortion services among health care providers for improved clarity regarding
the provision of safe legal abortion services.



There is need for a standard approach to improving the capacity of private providers to offer safe abortion
services including having a standard training curriculum, which incorporates counselling on proper use of
medication, family planning (especially long-term methods) and referrals for clients seeking abortion
services.



There is need to address some of the barriers to delivery and uptake of safe legal abortion services such as
stigma and lack of access to information through public awareness especially regarding existing laws and
policies on abortion and available services.



There is need to ensure proper packaging of medical abortion products and to address the issue of
counterfeits, for instance, by designing unique moisture-proof packages with bar codes that would be
difficult to imitate to reduce the chances of users getting substandard products which can compromise their
health.
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There need to improve the supply chain to reduce stock-outs of essential drugs (especially combined
Mifepristone and Misoprostol) in private pharmacies and clinics that provide abortion information or
methods.
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Background
The World Health Organization (WHO) estimates that globally, approximately 210 million pregnancies occur
each year with over 135 million resulting in live-born infants while the remaining 75 million end in stillbirth
or (spontaneous or induced) abortion (WHO 2011). Available estimates further show that there were 213
million pregnancies worldwide in 2012 with 85 million (40 per cent) of them being unintended and half of
the unintended pregnancies resulting in abortion (Sedgh et al. 2014). Most of the abortions are considered
unsafe i.e. they are performed by untrained practitioners or provided in unhygienic settings (Singh et al.
2009; WHO 2004). Unsafe abortion accounts for 13 per cent (47,000) of global maternal deaths worldwide
while about 60 per cent of abortion-related deaths take place in Africa (Shah and Åhman 2010; United
Nations 2010).
Globally, WHO estimated that there were 21.6 million unsafe abortions worldwide in 2008 with Africa having
the second highest rate of unsafe abortion (28 per 1,000 women aged 15-44 years) after Latin America and
the Caribbean which had a rate of 35 (WHO 2011). The rate of unsafe abortions was also higher in regions
with restrictive compared to those with less restrictive abortion laws (WHO 2011). Studies show that although
abortion is restricted in many countries in sub-Saharan Africa except for circumstances when the pregnancy
endangers the life of the mother, abortion-related complications account for the majority of admissions to
gynecological wards of hospitals in the region (Levandowski et al. 2012, 2013; Singh et al. 2005).
In Kenya, the maternal mortality ratio remains high at 488 deaths per 100,000 live births with 35 per cent
of these deaths arising from unsafe abortion (Centre for Reproductive Rights 2010; Kenya National Bureau
of Statistics [KNBS] and ICF Macro 2010; Ministry of Health 2003). A 2013 study that used patient-specific
data for women who sought abortion-related care at health facilities found that the rate of induced abortions
in the country was 48 per 1,000 women aged 15-49 years in 2012, higher than the 2002 rate of 45 per
1,000 women (Republic of Kenya 2013). The study further found that 37 per cent of the women seeking
post-abortion care services had severe complications such as high fever, sepsis, shock and organ failure,
indicating that abortion might have occurred under unsafe conditions (Republic of Kenya 2013).
Public debate on abortion and on proposals to liberalize the abortion law has been on-going for several years
in Kenya (Brookman-Amissah and Moyo 2004). With the passing of a new Constitution in 2010, there was
renewed interest in the right to health and the need to reduce the high levels of maternal morbidity and
mortality arising from unsafe abortion in the country (Republic of Kenya 2010a; 2012). In 2012, for instance,
the Government issued Standards and Guidelines for Reducing Morbidity and Maternal from Unsafe
Abortion that emphasized professional non-judgmental counseling and provision of safe options in cases of
unplanned, risky or unwanted pregnancies in line with the Constitution (Republic of Kenya 2012). The
Constitution, on the other hand, stipulates that abortion is permissible if in the opinion of a trained health
professional, there is need for emergency treatment, or the life or health of the mother is in danger or as
determined by any other law (Republic of Kenya 2010a). Furthermore, Article 43(1)(a) of the Constitution
states that every person has the right to the highest attainable standard of health, which includes the right
to health care services, including reproductive health care (Republic of Kenya 2010a).
Apart from the legal and policy discourses, medical abortion using a combination treatment of Mifepristone
and Misoprostol has been classified by WHO as a safe and effective method to stop a pregnancy up to 9
completed weeks since the last menstrual period i.e. during the first trimester (WHO 2012). Misoprostol is
registered in Kenya as a multi-purpose drug whose indications include duodenal ulcer, gastric ulcer,
treatment of incomplete abortion and miscarriage, treatment and prevention of post-partum haemorrhage
(PPH), treatment of intrauterine fatal death and cervical ripening. Mifepristone is also registered as a
medication indicated for duodenal ulcer, gastric ulcer, cervical ripening and as a uterotonic drug to induce
or increase uterine contractions. The availability of these two drugs in the country could replace surgical and
non-surgical invasive methods that have previously been used to terminate pregnancies, both illegally and
legally (Ong’ech et al. 2008).
In spite of the developments, there is limited understanding of the extent to which the changes have
influenced the provision of medical abortion information and services in the country, the acceptability of the
practice among providers and clients, and the content of care offered. This report presents findings from a
study whose aim was to generate evidence on the current knowledge about medical abortion, availability of
the services, as well as the nature of information exchange between clients and private providers (clinics
and pharmacies). The study was conducted in three counties, namely, Nairobi, Kisumu, and Mombasa
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between April and June 2013. The counties were purposively selected based on availability of private clinics
that were likely to provide medical abortion drugs. Private providers were targeted because access to
information and services on medical abortion in Kenya is mainly through private practitioners while public
health facilities mostly provide post-abortion care services (Wamugi et al. 2014). In addition, the counties
have varied levels of reproductive health indicators such as contraceptive use (63% in Nairobi, 62% in
Kisumu and 55% in Mombasa) and fertility (2.7 children per woman in Nairobi, 3.6 in Kisumu and 3.2 in
Mombasa; KNBS et al. 2014).
The subsequent sections of this report are divided into three major parts based on the key institutions that
were included in the study, namely, organizations with interest in reproductive health, private pharmacies,
and private clinics. Each part provides a brief introduction including the objectives of gathering information
from the institutions, methods, key findings and implications of the findings. The study obtained ethical
approval and research clearance from the Institutional Review Board of the Population Council, the Ethics
Review Committee of Kenya Medical Research Institute (KEMRI), the National Council for Science and
Technology (NCST), and Marie Stopes International Ethical Review Committee. Written informed consent was
obtained from all participants before data collection.
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Abortion Environment in Kenya:
Perspectives of Key Informants
INTRODUCTION
Institutions working in the field of reproductive health can contribute to improved client outcomes through
policy formulation, advocacy, program implementation, research to generate evidence to inform policy and
programming, as well as funding of programs. With respect to abortion in Kenya, some of the institutions
that have been at the forefront of promoting public debate on the issue since 2004 include an alliance
formed by the Kenya Medical Association (KMA), the Kenya Obstetrics and Gynaecology Society (KOGS), the
Federation of Women Lawyers and Ipas (Brookman-Amissah and Moyo 2004). The 2010 Constitution
generated further debate on the issue especially regarding the meaning of reproductive health, trained
health professional, or the phrase “as determined by any other law”. For instance, the Constitution does not
provide a definition of health or reproductive health but according to the 1994 International Conference on
Population and Development (ICPD), reproductive health is a state of complete physical, mental and social
well-being and not merely the absence of disease or infirmity in all matters relating to the reproductive
system and to its functions and processes (United Nations 1994). Since Kenya was a signatory to the 1994
ICPD, the right to reproductive health care as enshrined in the Constitution can therefore be interpreted to
include safe legal abortion, which is an important component of reproductive health services within a country
(WHO 2004).
Apart from advocacy, other private sector institutions have focused on providing safe legal medical and
surgical abortion services to clients. The Reproductive Health Network (RHN), for instance, is a network of
public and private sector service providers committed to reducing maternal morbidity and mortality
associated with unsafe abortion (Reproductive Health Network 2015). The Kenyan Chapter of Africa Network
for Medical Abortion (ANMA) brings together private sector providers providing medical abortion. The
institutions have also strengthened the referral systems by creating networks of gynaecologists, clinical
officers, nurses and midwives. Informed by the Ministry of Health’s (MOH) community strategy (Ministry of
Health 2006), the institutions have engaged community health workers to identify and refer clients with a
view to increasing access to safe abortion services in order to reduce maternal morbidity and mortality arising
from unsafe abortions. There are also various community initiatives to increase access to reproductive health
services. For example, the Male Involvement in Safe Abortion (MISA) project run by Kisumu Medical and
Education Trust (KMET) in Kisumu trains men to be reproductive health champions in the community and to
make referrals (KMET 2014). KMET also implements Sisterhood for Change project which trains teenage
mothers in life skills and to advocate for their rights to enable them act as change agents in their
communities (KMET 2014).
Other institutions have focused on enhancing the capacity of providers to address unsafe abortion through
in-service training. Trainings have focused on comprehensive abortion care (including medical and surgical
abortions) to improve the safety of abortion services, and on values clarification and attitude transformation
(VCAT) to address the negative attitudes and beliefs about abortion. Organizations such as ANMA,
Reproductive Health and Rights Alliance (RHRA), RHN and KOGS have been at the forefront in the
development of training curricula and training of service providers. The cadres of providers trained are those
that fall within the legal definition of a health professional including doctors, clinical officers, nurses and
midwives. Most training has been for middle level providers (clinical officers, nurses and midwives) since
they are the majority from whom poor women seek care. Mid-level providers are mostly trained to conduct
abortions up to 12 weeks gestation, while an abortion in the second trimester can only be performed by
doctors and gynaecologists. Some organizations (such as ANMA) have also started training pharmacists on
making the right decisions when women seek to buy Misoprostol over the counter and also to refer the clients
to the nearest ANMA member (ANMA Kenya 2014).
Based on the prevailing legal, policy and program environment regarding abortion, a key question is how the
actors view the developments in the context of provision of quality care to clients. The prevailing environment
may also determine whether the institutions allocate resources (human or financial) to influence policy and
programs. The objectives of this component of the study were therefore:
1) To understand the contextual and programmatic factors that influence or are likely to influence the
provision of medical abortion services in Kenya; and
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2) To explore the perspectives (positive and negative) of various stakeholders about abortion generally
and the provision of medical abortion services specifically.

METHODOLOGY
A total of 19 key informant interviews were conducted with the senior managers from national and locallybased international institutions with interest in reproductive health in general and medical abortion in
particular. The institutions were purposively selected to represent policy, program, research and donor
interests. The institutions comprised the Ministry of Health, KOGS, the National Nurses Association of Kenya
(NNAK), the Kenya Clinical Officers Association (KCOA), the University of Nairobi Department of Obstetrics
and Gynaecology, Marie Stopes Kenya (MSK), Family Health Options Kenya (FHOK), the Kenya Chapter of
the Africa Network for Medical Abortion (ANMA), the Reproductive Health Network (RHN), Reproductive
Health and Rights Alliance (RHRA), Ipas, Woman Care Global, the International Planned Parenthood
Federation (IPPF), Kenyatta National Hospital (KNH) and KMET. Each institution identified one senior
manager who provided information on the state of medical abortion services in Kenya.
Key informants were persons aged 18 years and above. The interviews were conducted in English and were
tape-recorded with the consent of the informants. The interviews were transcribed, typed in Word and
analysed for content using NVIVO software. Analysis involved coding of themes and categorizing the themes
within a hierarchical framework of main and sub-themes. The thematic framework was used to compare and
contrast patterns of the themes between different key informants. The data from the interviews provide
contextual information on the status of medical abortion in Kenya.

FINDINGS
Key informants reported that since the enactment of the 2010 Constitution, the abortion environment has
been changing rapidly especially with respect to the legal and policy frameworks, training of service
providers, service delivery, and availability of abortion commodities (equipment and drugs) although
challenges remain.

Legal and Policy Frameworks
Key informants noted that there have been some developments in the legal and policy frameworks regarding
abortion in Kenya. For instance, all key informants felt that the Standards and Guidelines for Reducing
Morbidity and Mortality from Unsafe Abortion in Kenya was a good reference material that offered clear
guidance for health workers who offer abortion services, as well as clarifying situations in which the health
worker might not be willing to provide services due to personal beliefs. As one key informant noted:
So far I think it’s [the Standards and Guidelines] a good one. I think its good enough to start off with. We
can improve. It is giving the women and the service providers all the options. If you have an unwanted
pregnancy, it gives you the option to adoption. The last part of it takes care of all the providers. The last one
was only the doctors or a psychiatrist. If the providers are educated on it well, they can understand it well.
I feel it’s a good one. We now have a reference material.

Despite availability of the standards and guidelines document, key informants noted that it is yet to be
disseminated widely, which has in turn affected its full implementation. MOH representatives stated that
dissemination has been hampered by lack of adequate funds. In addition, the MOH has not issued a policy
statement (through a circular or otherwise) that can be followed by public health facilities. These policy gaps
have sometimes been exploited by the police to harass health workers known to provide abortion services
legally. Key informants reported that:
Very few people even at our level know what the guidelines say. It was just last week we were planning to do
a survey in [name of facility] to look at the efficacy and efficiency of the two tier levels on the use of Misoprostol
and post-abortion care. When we applied for approval from the hospital ethical committee, the first comment
they gave us was by asking who gave midwives the authority to offer post-abortion care. So I had to come
back to the office and carry a hard copy. The issue is that people are not aware, there are documents and so
we need to disseminate.
The legislation/policy needs to be very clear, and then we need to sensitize the health workers across the
board for them to understand how the law protects them. It is a journey. But just saying the constitution has
been passed and the standards and guidelines have been developed won’t work.
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Training of Service Providers
Key informants reported that in spite of the provider trainings that have been undertaken by various
organizations, major skills and performance gaps in safe abortion services among health care providers
remain. These include:
 Poor knowledge of treatment protocols and drug dosages: This was largely because most health
care providers have not read the protocols and drug specifications as outlined in the service
standards and guidelines document.
 Poor counselling skills: Apart from nurses, other cadres of health care providers lack adequate
counselling skills, which were attributed to lack of pre-service training.
 Poor surgical skills: Some doctors were reported to have the medical knowledge but lack practical
skills for performing surgical abortion.
 Lack of skills in patient assessment specific to abortion: Many providers have skills in general
patient assessment, but lack skills specific to abortion including physical examination.
 Poor skills in infection prevention and management of abortion complications: This is mostly among
mid-level service providers (clinical officers, nurses and mid-wives).
 Lack of service integration: This is particularly with respect to linking women to other services such
as family planning.
The informants reported that the skills and performance gaps could be addressed through well planned inservice trainings on safe abortion in the short term but will require to be incorporated in the pre-service
curriculum in the long term. They further noted that in-service trainings should follow a standard curriculum
to ensure that there is a common approach to provision of safe abortion services as opposed to a situation
where trainings are done using different curricula developed by different institutions as has been the case.

Service Delivery
Key informants reported that, ideally, it should be possible for a woman to receive safe and legal abortion
services in public health facilities. However, the focus in the public sector is still on the management of postabortion complications. There is still reluctance and apprehension to provide medical abortion services
mainly due to the lack of a clear policy statement on abortion in the public sector. Key informants further
noted that besides the limited dissemination of the standards and guidelines, provision of safe abortion
services in public health facilities is hindered by negative provider attitudes and beliefs. It was reported that
some health care workers decline to offer services due to their religious beliefs (i.e. conscientious objection)
or the widespread social stigma associated with abortion. A health care provider reported that:
I do not mind what the Constitution says, my personal opinion is that we need to address. I think telling people
the solution to irresponsible sexual behaviour is abortion [is wrong]. I think people are worried about
pregnancy and not the consequences of unprotected sex, that is what we need to address. In emergency
cases where there is rape and other cases, the services can be availed, but in situations where it is at will and
in the era of HIV/AIDS, we need to be cautious.

Informants identified various challenges/barriers to women’s ability to access safe medical abortion services
to include:
 Stigma: Both the women seeking the services and the providers offering the services are
stigmatized, for example, being referred to as ‘baby killers’. Facilities identified to be offering safe
abortion services are also stigmatized by the general public.
 Inadequate number of trained health providers: Although progress has been made with in-service
training of health workers, the numbers are still insufficient to meet demand.
 Inadequate supply of drugs: Whereas Misoprostol and Mifepristone are registered, the distribution
network is not yet well established. The drugs are readily available in major urban areas but scarce
in small towns and rural areas.
 Cost: The price of the drugs in areas where there is limited supply was also reported to be out of
reach of poor women and the youth. For instance, while the actual cost of Misoprostol could be as
low as KSh. 20, it was reported that in some places it could cost as high as KSh. 1,000.
 Ignorance about the law: Many people are still not aware of the provisions of the Constitution
regarding abortion services. Furthermore, others interpret the law narrowly in order to deny women
services.
 Limited number of facilities that provide safe abortion services: There are not many publicly known
facilities that provide the services, while those that do are mostly found in urban areas and are
mainly privately owned. In addition, lack of clear policy statement has acted as a barrier to the
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provision of safe abortion services in public health facilities.
Quality of care: This is affected by the secretive nature of providing abortion services; hence clients
may obtain counterfeit commodities from people operating unregistered facilities. Providers’ poor
counselling skills as well as lack of awareness about service standards and guidelines also affect
quality of care.
Poor access to information: Women in urban slums and rural areas and especially younger women
lack information on where to get safe abortion services and/or advice.

Availability of Supplies, Equipment and Drugs
Informants noted that the registration of medical abortion drugs—Misoprostol and Mifepristone—represented
major progress towards addressing unsafe abortions in Kenya. Misoprostol has also been included in the
essential drug list which makes it possible for public health facilities to procure it. Various stakeholders,
including drug companies, non-governmental organizations and networks of providers, now procure and
distribute abortion drugs and equipment to private health facilities that are in need. However, informants
identified a number of challenges affecting the supply chain (importation, storage, distribution and
marketing) of medical abortion commodities. They noted that the challenges are severe at the
supply/distribution stage, as evidenced by the pricing of medical abortion drugs. As one informant noted:
As I said, the main challenge is the distribution outlets. If you are in [name of town], you need to go there and
get the products at an affordable price. One time in [another town], I walked into a chemist and asked for
Misoprostol, the lady told me I needed a prescription but I managed to convince her I was a health worker
and she accepted. One tablet goes for KSh. 600 while a tablet here [name of facility] goes for KSh. 20, so you
can imagine how many women are suffering. So the problem is at distribution and the cost.

The specific challenges with the supply chain that informants identified included:
 Importation bottlenecks: Similar to other medical products, challenges with importing medical
abortion drugs and surgical abortion kits include paying for the products upfront, theft at customs,
and delays in clearance by the customs authorities. These processes are time consuming and result
in delays in getting the products to those who need them.
 High price of products: The price of abortion products was noted to be generally high and this is
occasioned by poor supply and distribution channels. There are very few companies and
organizations involved in the procurement of abortion commodities. The limited distribution
channels in the country pushes the prices of commodities beyond the reach of health facilities and
clients.
 Poor packaging and storage of drugs: Poor packaging of Misoprostol has been experienced, with
some batches absorbing moisture, especially when poorly stored.
 Availability of counterfeits: Counterfeits are available for Misoprostol and manual vacuum aspiration
(MVA) kits especially in Nairobi. The supply of counterfeits compromises the provision of safe
abortion services since quality cannot be guaranteed. Counterfeits also affect the pricing of
commodities and legitimate providers are likely to lose out.

SUMMARY AND IMPLICATIONS
Summary of Findings


Although there has been progress in the legal and policy frameworks regarding abortion to increase the
availability of safe and legal services, many service delivery challenges still persist. Limited
dissemination of relevant documents and lack of clear and officially endorsed policy statements to guide
public health facilities mean that there is a lack of awareness about the revised service standards and
guidelines among service providers and the conditions under which safe abortion services can be legally
provided.



Although several non-governmental organizations and professional associations have developed
curricula and supported training of service providers, especially from the private sector, on
comprehensive abortion care, values clarification and attitude transformation and referrals, there is no
standard training curriculum while skills gaps still persist among providers.



Effective delivery of safe legal abortion services are further affected by societal stigma, poor access to
appropriate information especially among those from marginalised settings, inadequate supply of drugs
due to few established distribution channels, poor packaging and storage of relevant drugs, availability
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of counterfeits, and price distortion brought about by some of these challenges.

Implications


There is need for widespread and government-endorsed dissemination of the revised laws, policies,
standards and guidelines on abortion services among health care providers for improved clarity
regarding the provision of safe legal abortion services.



The finding that gaps still exist with respect to provider skills despite trainings conducted by different
partners suggest the need for a standard approach to improving the capacity of providers to offer safe
abortion services including having a standard training curriculum.



There is need to address some of the barriers to delivery and uptake of safe legal abortion services such
as stigma and lack of access to information through public awareness especially regarding existing laws
and policies on abortion and available services.



There is need to ensure proper packaging of medical abortion products and to address the issue of
counterfeits, for instance, by designing unique moisture-proof packages with bar codes that would be
difficult to imitate to reduce the chances of users getting substandard products which can compromise
their health.
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Abortion Services in Private
Pharmacies
INTRODUCTION
Private pharmacies in Kenya play a critical role in ensuring access to essential medicines by those in need.
The 2010 Kenya National Pharmaceutical Policy (KNPP) recognizes the right to access essential medicines
especially by vulnerable population groups as part of the fundamental right to health as enshrined in the
Constitution (Republic of Kenya 2010b). According to the policy, registered pharmacists and enrolled
pharmaceutical technologists are the only cadres of health personnel qualified to dispense medicines and
operate private pharmacies in the country (Republic of Kenya 2010b). However, private pharmacies face
challenges that might affect the way consumers benefit from essential medicines. From a public health
perspective, private pharmacies may lack the incentives to take up important steps in promoting rational
decision-making by consumers including counselling on proper use of medicines or providing referrals for
appropriate care. This could be attributed to the nature of training for pharmacists (which may not include
the provision of public health information and services) and the fact that interactions with clients at private
pharmacies are mostly with frontline staff some of whom lack formal training in health service provision
(PATH 2004). Private pharmacy providers are further faced with the challenge of balancing operations as a
business establishment and performing the role of health service providers (Skibiak et al. 2001; PATH 2004).
The registration of Mifepristone and Misoprostol in Kenya made them part of the essential drugs list for
distribution and sale through registered outlets including private pharmacies. The medications are
distributed to registered private pharmacies and clinics by recognized distributors including Marie Stopes
International for Misoprostol and Maxima Pharmaceuticals Limited for Mifepristone. The medications are
registered for sale over the counter with prescriptions from a medical practitioner. Challenges associated
with medicines being sold as commodities as well as those faced by private pharmacies may affect the way
the two medications are sold to and used by consumers. There is, however, limited understanding of private
pharmacy providers’ knowledge of the medications and existing regulations, how they dispense the
medications and how they generally interact with clients seeking abortion services. The objectives of this
component of the study were:
1) To assess the availability of Mifepristone and Misoprostol or other abortifacient as well as the skills
and practices of workers in private pharmacies;
2) To examine the knowledge and attitudes of private pharmacy workers regarding Mifepristone and
Misoprostol or other abortifacients; and
3) To explore the information given to clients seeking medical abortion services at private pharmacies.

METHODOLOGY
This component of the study involved structured interviews with private pharmacy workers and simulated
client visits to the pharmacies.

Interviews with Pharmacy Workers
In each county, 100 pharmacies were randomly sampled from the list of all registered private pharmacies.
It is common for pharmacies and chains of pharmacies to be owned by one proprietor who employs workers
to provide services to clients. For each sampled pharmacy, the owner was approached to provide written
informed consent for his/her pharmacy to be included in the study. Of the 300 sampled pharmacies, owners
of 274 granted consent (82 in Nairobi, 93 in Kisumu and 99 in Mombasa). Subsequently, trained research
assistants visited these 274 pharmacies to conduct interviews with the pharmacy workers. One most senior
pharmacy worker was interviewed in each pharmacy. To be eligible for interview, the pharmacy worker had
to be actively involved in dispensing drugs, should have worked for at least six months at the pharmacy, and
gave individual written informed consent. Interviews were completed with 235 pharmacy workers (82 in
Nairobi, 80 in Kisumu and 73 in Mombasa), 36 refused (11 in Kisumu and 25 in Mombasa) while 3
interviews were only partially completed (2 in Kisumu and 1 in Mombasa).
The interviews aimed at determining the availability of medical abortion services as well as knowledge,
attitudes and practices of the workers regarding the services. Information was captured on the background
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characteristics of pharmacy workers (sex, age, education level and training), their knowledge of medical
abortion products and regimens, service provision practices at the pharmacy, and the cost of Misoprostol
and Mifepristone. Pharmacy workers were approximately equally male and female, with an average age of
31 years (range of 22 to 58 years). Nearly all (97%) had secondary education and above. The majority (56%)
worked at pharmacies in peri-urban areas, 34% were in pharmacies in the central business district of each
urban centre, while 10% were in rural areas. The majority (80%) were employees and 92% reported that they
were trained to dispense medicines.
Simulated Client Visits
The simulated client approach was used to understand service provision practices followed for clients
seeking abortion services at pharmacies. Simulated clients were females aged between 18 and 31 years,
and trained to assume one of the following four specific profiles of clients seeking medical abortion services
from a pharmacy:
 Scenario 1: A woman specifically wanting to purchase Misoprostol without stating a reason;
 Scenario 2: A woman specifically wanting to purchase Misoprostol and stating that the reason is to
end a pregnancy without stating the gestation period;
 Scenario 3: A woman seeking any medication to end an 8-week pregnancy; and
 Scenario 4: A woman seeking any medication to end a 12-week pregnancy (i.e. after the
recommended threshold gestation).
In each county, about half of the pharmacies whose workers were interviewed were visited by simulated
clients. A total of 401 simulated client visits were made (136 in 53 pharmacies in Nairobi, 134 in 49
pharmacies in Kisumu, and 131 in 40 pharmacies in Mombasa). Each pharmacy was visited an average of
three times (minimum one, maximum 4) on different dates at least one week after the structured interviews
with the pharmacy workers, over a period of one month. The minimum time period between visits was three
days. No pharmacy was visited more than once by the same simulated client. Within one hour of each visit,
the simulated client completed a structured questionnaire to record details of their interaction with the
pharmacy workers including any information and product they were given. The visits were equally distributed
among the four scenarios, i.e. 100 visits per scenario.

Data Analysis
Data from structured interviews with pharmacy workers and simulated client visits were entered in EpiData
and analysed using STATA. Analysis involved simple descriptive statistics including percentages, means and
medians. For simulated client data, Chi-square tests were performed to determine if differences between
scenarios were statistically significant.

RESULTS
Staffing Levels and Staff Training
The median number of staff at the pharmacies was 8 with a minimum of 1 and maximum of 8 persons. Only
16% of the pharmacy workers who reported that their outlets provided abortion services (information or
methods) had been trained on the provision of the services with wide variations between counties (52% in
Nairobi, 15% in Kisumu and 2% in Mombasa). In addition, 10% of the pharmacy workers who reported that
their outlets did not provide abortion services indicated that they had been trained to provide the services
(12% in Nairobi, 11% in Kisumu and none in Mombasa). Pharmacy workers who indicated that they had been
trained were asked to specify the aspects in which they had been trained (Figure 1). Most had been trained
in ensuring confidentiality and privacy of clients (97%), history taking (91%), and pain management (88%),
and relatively few had been trained in the national standards and guidelines (34%), record-keeping and
reporting (38%) and criteria for referral procedures (38%).
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Figure 1: Per cent distribution of pharmacy workers who had been trained on provision of abortion services by training
specific aspects
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Misoprostol-only regimen was the most common method that pharmacy workers had been trained in,
followed by MVA, dilatation and curettage, and dilatation and evacuation (Figure 2). Less than 10% of the
trained pharmacy workers had been trained in Mifepristone-only (6%) or the recommended combination of
Mifepristone and Misoprostol regimens (9%).
Figure 2: Per cent distribution of pharmacy workers who had been trained on provision of abortion services by specific
methods
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Availability of Abortion Services
More than half (58%) of the pharmacy workers interviewed indicated that they provided advice or information
on pregnancy termination to clients seeking the services although there were wide variations by county (65%
in Kisumu, 29% in Nairobi and 84% in Mombasa). The most commonly provided information were referral to
a health facility (71%), continuing with the pregnancy (60%), and seeking counselling services on how to
manage the pregnancy (36%). Only 4% of the pharmacy workers reported that they provided methods of
pregnancy termination to clients seeking the services (1% each in Kisumu and Mombasa and 9% in Nairobi).
Nine out of ten provided Misoprostol only. Ninety five per cent of the pharmacy workers whose outlets
provided abortion information or methods indicated that they sold family planning methods as well, which
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provides an opportunity to offer such clients the methods. The most commonly sold methods in these outlets
were pills (95%), male condoms (91%), emergency contraceptives (89%), and the 3-month injectables (75%).
Among pharmacies whose workers reported that they provided abortion information or methods, 18%
indicated that they sold Misoprostol only, 2% sold Mifepristone only while none sold the combination of
Mifepristone and Misoprostol. The most commonly reported reasons for selling the medications were for
controlling peptic ulcers (68%), labour induction (28%), controlling postpartum haemorrhage (24%), and
treating incomplete abortion (12%).
About two-thirds (67%) of the pharmacy workers who reported that they did not provide abortion information
or methods indicated that clients asked for those services. In most cases, they referred clients elsewhere
(49%) or advised them against procuring an abortion (40%). Those who reported referring clients elsewhere
mostly referred them to private health facilities (78%). Others made referrals to public health facilities (54%)
and general practitioners (8%).

Availability of Drugs and Supplies
Among pharmacies that provided information or methods on abortion, the most commonly available supplies
were policy on confidentiality of clients (89%), policy on record-keeping and reporting (87%), Misoprostol
(66%), and referral mechanisms (52%). The least available items were Mifepristone (2%), WHO Technical
and Policy Guidance on Safe Abortion and the National Standards and Guidelines for abortion care (Figure
3).
Figure 3: Per cent distribution of pharmacies providing abortion information or methods by availability of drugs and
supplies
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Prices of Medical Abortion Methods
The average price of Misoprostol based on information obtained from pharmacy workers ranged from KSh.
74 (≈US $0.87) to KSh. 530 (≈US $6) depending on the brand (Table 1). The average price of Mifepristone
was KSh. 73 (≈US $0.86). However, the prices quoted for simulated clients were much higher, ranging from
KSh. 391 (≈US $4.60) to KSh. 2,116 (≈US $24) depending on the scenario presented (Table 1).
Table 1: Minimum, maximum, and median prices of medical abortion methods in private pharmacies

Method
Brands of Misoprostol
Misoclear
Cytotec-pharmacia UK
Isovent
Arthrotec
Mifepristone Linepharma 200mg
Misoprostol only
Scenario 1
Scenario 2
Scenario 3
Scenario 4
All four scenarios
Mifepristone only
Notes:

Minimum
(KSH)

Maximum
Median
(KSH)
(KSH)
Prices given by pharmacy workers

Number of
pharmacies

30
35
50
50
65

300
60
350
100
120
60
2,890
55
80
73
Prices quoted for simulated clients

38
54
9
6
2

50
200
280
320
50
400

3,000
4,000
3,500
5,000
5,000
1,000

100
800
2,500
1,000
450
700

23
7
5
11
46
2

Standard deviations for means are in parentheses; KSH: Kenya shilling (1 USD ≈ KSH. 85).

Knowledge and Attitudes of Pharmacy Workers
Misoprostol alone was the most commonly known abortion medication among private pharmacy providers
(86% of males and 76% of females) followed by Mifepristone alone (46% of males and 28% of females) while
the combination of Mifepristone and Misoprostol was the least known (Figure 4). However, only 22% of males
(N=103) and 16% of females (N=86) who had heard of the medications mentioned the correct regimen for
Misoprostol only for pregnancies of various gestational ages. Similarly, only 13% of males (N=55) and 3% of
females (N=32) mentioned the correct regimen for combination of Mifepristone and Misoprostol (Figure 4).
A small proportion (3%) of the pharmacy workers felt that clients seeking abortion services should be able
to get the drugs from pharmacies without a prescription.
Figure 4: Per cent distribution of pharmacy workers by knowledge and attitudes regarding abortion
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Service Provision Practices
Slightly more than a quarter (27%) of pharmacy workers whose outlets provided abortion information or
methods reported ever denying clients the services (32% of males and 20% of females; Table 2). The most
common reasons for denying clients the services were religious or moral beliefs (57%), lack of trained
provider (38%), lack of permission from third parties (19%), lack of appropriate equipment (14%), and lack
of prescription from a medical practitioner (11%). In addition, 35% of pharmacy workers whose outlets
provided abortion information or methods indicated that they screened clients (31% of males and 40% of
females) while 7% advised clients to return for follow-up visits (8% of males and 7% of females; Table 2).
Screening of clients mostly involved asking for reasons of seeking to terminate pregnancy, asking about
gestational age of the pregnancy, asking about client’s background characteristics, conducting medical
examination, asking for prescription, asking about medical history, and asking for proof of permission from
third parties (not shown).
Table 2: Per cent distribution of pharmacy workers by practices regarding abortion
Indicator
Instances of pharmacy denying abortion clients
servicesa
Reasons for denying abortion clients services
Lack of prescription
Lack of permission from third parties
Client could not afford to pay
Stock-out of essential drugs
Lack of appropriate equipment
No trained provider
Religious/moral beliefs
Providera
Screens clients seeking abortion services
Advises clients to return for follow-up
Notes:

aAmong

Male
(%)
32.1
(N=78)
(N=25)
4.0
24.0
4.0
8.0
12.0
40.0
64.0
(N=78)
30.8
7.7

Female
(%)
20.0
(N=60)
(N=12)
25.0
8.3
8.3
0.0
16.7
33.3
41.7
(N=60)
40.0
6.7

Both sexes
(%)
26.8
(N=138)
(N=37)
10.8
18.9
5.4
5.4
13.5
37.8
56.8
(N=138)
34.8
7.3

pharmacies providing information or services on abortion.

With respect to interactions with simulated clients, there were significant variations in the practices of
pharmacy workers by the scenario presented. In particular, the proportion of visits for which pharmacy
workers asked about the last menstrual period, gestational age, medical history, reasons for pregnancy
termination, and proof of permission from third parties were highest when simulated clients sought
medication to terminate a three-month pregnancy (scenario 4) and lowest when they just asked for
Misoprostol without stating reason (scenario 1; Table 3). Similarly, the proportion of visits for which pharmacy
workers advised clients to continue with the pregnancy or gave information about where to obtain pregnancy
termination services, available methods of pregnancy termination, and surgical abortion methods were
highest under scenario 4 and lowest under scenario 1. By contrast, the proportion of visits for which providers
asked for prescriptions from a medical practitioner and discussed medical abortion methods was highest
under scenario 1 (Table 3).
For all visits combined, pharmacy workers performed poorly on all indicators; the highest scores were for
asking about gestational age (55%) and advising clients on where to obtain services for pregnancy
termination (50%). In addition, despite the fact that most pharmacies providing abortion information or
services also sold family planning methods, family planning was discussed with simulated clients in only
12% of the visits (Table 3). Similarly, pharmacy workers recommended family planning in 9% of visits, offered
a method in 1% of visits, and referred clients elsewhere for family planning in 1% of visits (Table 3).
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Table 3: Per cent distribution of simulated client visits to private pharmacies by indicators of service provision and scenario presented

Indicator
History-taking and medical examination
Provider asked about last menstrual period
Provider asked about gestational age of pregnancy
Provider asked about medical history
Provider asked about reasons for terminating pregnancy
Provider asked about prescription
Provider asked about permission from third parties
Provider conducted medical examination
Counselling
Provider advised to continue with pregnancy
Provider advised to seek counselling before abortion
Provider advised where to obtain abortion services
Provider advised about available abortion methods
Provider discussed any surgical abortion method
Provider discussed any medical abortion method
Provider discussed family planning
Provider recommended family planning
Provider referred client elsewhere for family planning
Services
Provider offered surgical abortion method
Provider offered medical abortion method
Provider offered medication to manage pain
Provider offered medication for complications
Provider offered family planning method
Notes:
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Client asked for
Misoprostol without
stating reason:
scenario 1
(%)

Client sought help to
terminate pregnancy
without stating
gestational age:
scenario 2 (%)

Client sought
medication to
terminate 2-month
pregnancy: scenario
3 (%)

Client sought
medication to
terminate 3-month
pregnancy: scenario 4
(%)

6.9
28.7
0.0
13.9
44.6
0.0
3.0

39.0
50.0
6.0
57.0
24.0
3.0
4.0

32.7
75.3
2.0
48.5
13.9
12.9
5.0

74.8**
64.7**
18.2**
65.7**
33.3**
28.3**
7.1

38.2
54.6
6.5
46.1
28.9
11.0
4.7

9.9
16.8
27.7
6.9
5.0
48.5
5.9
5.0
0.0

45.0
12.0
50.0
37.0
29.0
19.0
7.0
7.0
1.0

24.8
6.9
53.7
28.7
26.7
14.9
18.8
10.9
0.0

59.6**
28.3**
69.7**
50.5**
50.5**
20.2**
16.2**
12.1
3.0*

34.7
16.0
50.1
30.7
27.7
25.7
12.0
8.7
1.0

2.0
5.9
2.0
2.0
0.0

5.0
10.0
1.0
1.0
1.0

11.9
5.9
11.9
12.9
0.0

11.1*
12.1
6.1**
5.1**
1.0

7.5
8.5
5.2
5.2
0.5

Differences between scenarios are statistically significant at: *p<0.05; **p<0.01.

All four scenarios
(%)

SUMMARY AND IMPLICATIONS
Summary of Findings


Very few pharmacy workers (16%) whose outlets provided abortion information or methods had been trained on
the provision of the services with trainings focusing more on ensuring confidentiality and privacy of clients, history
taking, and pain management, and less on the national standards and guidelines, record-keeping and reporting,
criteria for referral procedures and the recommended regimens for combination of Mifepristone and Misoprostol.



There was limited stocking of Misoprostol or Mifepristone even in pharmacies that provided abortion information
or methods with only 18% of such pharmacies selling Misoprostol, 2% sold Mifepristone while none sold the
combination of Mifepristone and Misoprostol. In addition, most of the pharmacies did not have the national
standards and guidelines document on reducing maternal mortality and morbidity from unsafe abortion.



There was limited knowledge of the correct regimen for Misoprostol only (22% of males and 16% of females) or
for combination of Mifepristone and Misoprostol (13% of males and 3% of females) for pregnancies of various
gestational ages among pharmacy workers who knew about the medications.



Although nearly all pharmacy workers (97%) felt that clients seeking Mifepristone and Misoprostol from
pharmacies should have a prescription from a medical practitioner, only 11% indicated having ever denied clients
abortion services because of lack of a prescription while the most common reasons for denial of services were
religious or moral beliefs or lack of a trained provider.



Pharmacy workers performed poorly on all indicators of interactions with simulated clients although the chances
of asking about gestational age (55% of interactions) and advising clients on where to obtain services for
pregnancy termination (50% of interactions) were higher than those of discussing family planning (12% of
interactions), recommending family planning (9% of interactions), offering a method (1% of interactions), or
referring clients elsewhere for family planning (1% of interactions).

Implications


There is need to improve the capacity of pharmacy workers to offer appropriate information including proper use
of medication, family planning and referrals to clients seeking abortion services.



There is need to improve the supply chain to reduce stock-outs of essential drugs (especially combined
Mifepristone and Misoprostol) in private pharmacies that provide abortion information or methods.



There is need for widespread dissemination of the existing policies and guidelines among pharmacy workers to
ensure that they provide services within existing regulations.
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Abortion Services in Private Clinics
INTRODUCTION
Private clinics in Kenya are operated by the cadres of providers that fall within the legal definition of a health
professional including doctors, clinical officers, nurses and midwives. The clinics are registered by the Kenya Medical
Practitioners and Dentists Board, the Clinical Officers Council or the Nursing Council of Kenya depending on the
qualification of the provider operating the clinic. It is also common for private providers to be part of a network or
franchise that aims at improving institutional sustainability of the clinics and the quality of care that they provide. In
spite of the regulatory and institutional oversight available for private clinics in the county, the nature of care provided
at the outlets may still be affected by other factors such as the resources at the disposal of the provider, availability
of appropriate services, choices that clients make, technical competence of providers as well as how they interact
with clients including mechanisms for follow-up (Bruce 1990).
In the context of abortion services, care at private clinics may be affected by some of the challenges identified by key
informants (see section on “Abortion Environment”) including inadequate training, limited awareness about relevant
policies and guidelines, poor supply and distribution chain for essential medicines, and the social stigma associated
with the practice. However, little is known about the provision of medical abortion in private clinics in the country, the
acceptability of the practice among providers and clients, as well as the content of care given to clients. The objectives
of this component of the study were:
1) To assess the availability of Mifepristone and Misoprostol or other abortifacient as well as the skills and
practices of providers in private clinics;
2) To examine the knowledge and attitudes of providers in private clinics regarding Mifepristone and Misoprostol
or other abortifacients;
3) To determine the characteristics, choices and perceptions of clients seeking abortion services from private
clinics; and
4) To explore the quality of care given to clients seeking abortion services from private clinics.

METHODOLOGY
This component of the study involved structured interviews with in-charges (managers) of private clinics, observations
of client-provider interactions during consultations, and structured exit interviews with clients seeking abortion
services.

Interviews with Facility In-charges
Structured interviews were conducted with facility in-charges of 45 private clinics that provide abortion services (11
in Kisumu, 18 in Nairobi, and 16 in Mombasa). The facilities were randomly sampled from among those that were
members of the Reproductive Health Network and/or the AMUA Franchise that is managed by Marie Stopes Kenya. A
minimum of 10 facilities were targeted in each County. The interviews with the in-charges included an inventory to
determine the available infrastructure, staffing levels and skills mix, equipment, commodities, and supplies needed
for surgical and medical abortion services. The facility in-charges were also asked about their knowledge and practices
as well as the prices of abortion services available at the facility. Almost one-half (47%) of the in-charges were nurses
or midwives, 36% were clinical officers, 9% were gynaecologists, and 9% were community health workers. Two-thirds
of in-charges were male. On average, the providers had worked in health care for 19 years, although females had
worked longer (average of 24 years) compared to males (average of 16 years).The providers had worked at the
facilities where they were interviewed for an average of 9 years with females having worked slightly longer (11 and 7
years respectively).

Observations of Client-Provider Interactions
Observations of client-provider interactions during consultations were in conducted in private clinics with clients and
providers who had given their consent to be observed during the provision of a medical abortion procedure. A total of
141 observations were conducted in 32 out of the 45 private clinics that were included in the study (62 in 11 clinics
in Kisumu, 58 in 12 clinics in Nairobi and 21 in 9 clinics in Mombasa). Two observations were partially completed (1
in Kisumu and 1 in Mombasa) because the clients needed referrals to higher level facilities. The observations were
conducted by trained nurses to determine the nature and quality of services that clients received. The nurses used a
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structured checklist adapted from the WHO Technical and Policy Guidance on Safe Abortion (WHO 2012) and the
National Standards and Guidelines for Reducing Morbidity and Mortality from Unsafe Abortion in Kenya (Republic of
Kenya 2012). They observed aspects of history taking, pre-procedure counselling, medical examination, provision of
medical abortion, and post-abortion care information provided to clients.

Client Exit Interviews
Immediately after the observations, consenting clients were requested to participate in an exit interview to determine
their perceptions of the services provided and their overall impression of the provider’s behaviour during the
consultation. Interviews were completed with 125 clients (48 in 11 clinics in Kisumu, 56 in 12 clinics in Nairobi and
21 in 9 clinics in Mombasa). Six interviews were partially completed and eight clients who were observed during the
consultation refused the interview. Information was collected on their background characteristics (such as age,
education level, marital status, religious affiliation, and household assets and amenities), childbearing experiences
and intentions, family planning knowledge and use, and perceptions about the services received. The interviews were
conducted in English, Kiswahili or a mixture of both depending on the clients’ preference by a research assistant who
was paired with the nurse conducting the observations.

Data Analysis
All data were entered in EpiData and analysed using STATA. Analysis involved simple descriptive statistics including
percentages, means and medians. Composite scores were computed to determine availability of drugs and supplies
as well as the quality of care that clients received. The results are presented in the form of the fraction of elements
that were available in the clinics or that were performed by providers during interactions with clients. Tables A1 and
A2 in the Appendix present the list of items that were used to compute the scores for service availability and quality
of care respectively.

RESULTS
Staffing Levels and Staff Training
The clinics had, on average, 4 medical and 1 support staff, with facilities in Nairobi having the highest median number
of providers, followed by those in Mombasa and Kisumu (Table 4). However, facilities had on average only 1 staff
member trained on medical abortion, comprehensive post-abortion care or family planning, while none was trained
on values clarification and attitude transformation. Facilities in Kisumu had higher numbers of staff members trained
on medical abortion and family planning (Table 4). Further analysis showed that the most common aspects related to
the provision of abortion services that clinic staff had received in-service training on were infection prevention (78%
of facilities), referral procedures (76%); and managing complications (76%; not shown). The least aspects that staff
had been trained on were the national standards and guidelines (60% of facilities) and the legal and policy provisions
regarding abortion (51%; not shown). Other aspects that staff had been trained on included pregnancy screening (67%
of facilities), communication/counselling (69%), medical examination of clients (69%), history taking (71%), pain
management (71%), record-keeping/reporting (71%), and confidentiality/privacy of clients (73%; not shown).
Table 4: Staffing levels and staff training in private clinics
Indicator
Median number of staff in facility
Medical staff
Support staff
All staff
Median number of staff trained on specific aspects
Medical abortion
Comprehensive post-abortion care
VCAT
Family planning
Notes:

Kisumu
(N=11)

Nairobi
(N=18)

Mombasa
(N=16)

All sites
(N=45)

3
2
3

5
1
6

4
2
5

4
1
5

2
1
0
2

1
0
0
1

1
1
0
1

1
1
0
1

VCAT: Values clarification and attitude transformation.
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Service Availability
Eighty per cent of the clinics offered at least one surgical abortion method and a similar proportion offered at least
one medical abortion method (Table 5). MVA was the most common surgical abortion method, while Misoprostol alone
was the most common medical abortion method available in the clinics. Almost all (91%) facilities offered either
surgical or medical abortion methods, while 69% offered both methods. Only 11% of the facilities had Mifepristone
alone, while 18% had a combination of Mifepristone and Misoprostol, reflecting the fact that Mifepristone had just
been registered a few months before the study.
More than 90% of facilities conducted or had conducted at least one procedure related to pre-abortion, pain
management, infection prevention or control, and management of complications (Table 5). However, only 33% of
facilities conducted all the procedures related to pre-abortion care, while none had conducted all the procedures
related to pain management, infection prevention or control, and management of complications. Virtually all facilities
(98%) reported that they provide family planning information or methods as a separate service. However, only 53%
reported that they provide additional information on when to seek further care and less than half reported providing
information on prevention of sexually transmitted infections (STIs) or HIV (49%), self-care after leaving the health
facility (42%), and resumption of sexual activity (15%; ).
Table 5: Per cent distribution of facilities offering various abortion-related services by study site

Service indicator
Surgical abortion methods
Manual vacuum aspiration
Electric vacuum aspiration
Dilatation and evacuation
Dilatation and curettage
Hysterotomy
Any surgical abortion method
All surgical abortion methods
Medical abortion methods
Misoprostol (Miso) alone
Mifepristone (Mife) alone
Combination of Mife and Miso
Any medical abortion methods
Surgical and/or medical methods
Surgical or medical methods
Surgical and medical methods
Pre-abortion processes (4 items)a
Any process (at least 1 item)
All processes (all 4 items)
Pain management procedures (6 items)a
Any procedure (at least 1 item)
All procedures (all 6 items)
Infection prevention and control (6 items)a
Any process (at least 1 item)
All processes (all 6 items)
Management of complications (8 items)a
Any procedure (at least 1 item)
All procedures (all 8 items)
Family planning
Information
Methods
Other information services
When to seek further care
Prevention of STIs/HIV
Self-care after leaving facility
Resumption of sexual activity
Notes:
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aSee

Kisumu
%
(N=11)

Nairobi
%
(N=18)

Mombasa
%
(N=16)

All sites
%
(N=45)

54.6
9.1
27.3
27.3
9.1
72.7
0.0

72.2
5.6
22.2
27.8
0.0
77.8
0.0

87.5
0.0
0.0
6.3
0.0
87.5
0.0

73.3
4.4
15.6
20.0
2.2
80.0
0.0

81.8
0.0
27.3
90.9

50.0
5.6
11.1
61.1

93.8*
25.0
18.8
93.8

73.3
11.1
17.8
80.0

90.9
72.7

83.3
55.6

100.0
81.8

91.1
68.9

100.0
45.5

94.4
22.2

87.5
37.5

93.3
33.3

100.0
0.0

100.0
0.0

100.0
0.0

100.0
0.0

100.0
0.0

83.3
0.0

100.0
0.0

93.3
0.0

100.0
0.0

94.4
0.0

93.8
0.0

95.6
0.0

100.0
100.0

100.0
100.0

93.8
93.8

97.8
97.8

63.6
72.7
54.6
36.4

50.0
33.3
27.8
5.6

50.0
50.0
50.0
6.3*

53.3
48.9
42.2
14.9

Table A1 in the Appendix section for the list of items; STIs: Sexually transmitted infections; Differences between study
sites are statistically significant at: *p<0.05; **p<0.01.

Availability of Drugs, Supplies and Equipment
Interviewers asked facility in-charges and also requested to see whether various drugs, supplies and equipment for
abortion services were available at the facility and in stock on the day of the visit. The clinics had most of the drugs
and supplies for surgical abortion (81% of items) as well as for recovery, pain management and treatment of
complications (85% of items; Table 6). However, the proportions of these items that were in stock on the day of
interview were lower than what was reported to be available. The clinics also had most of the infrastructural facilities
needed to ensure quality care for clients (91% of items; Table 6). The facilities also had about two-thirds of the
equipment for surgical or medical abortion (68% of items) and services standards and guidelines on abortion (69% of
items). Availability of drugs and supplies for medical abortion at the clinics was very low (15%) although the proportion
of items that were in stock on the day of interview was similar to what was reported to be available (Table 6).
Table 6: Availability of drugs, supplies, and equipment by study site
Indicator
Drugs and supplies for surgical abortion (16 items)
Available in facility
In stock on day of visit
Drugs and supplies for medical abortion (10 items)
Available in facility
In stock on day of visit
Drugs and supplies for recovery, pain management and
complications (6 items)
Available in facility
In stock on day of visit
Equipment for surgical or medical abortion (21 items)
Available in facility
In stock on day of visit
Service standards and guidelines (5 items)
Infrastructure scores (9 items)

Kisumu
(%)
(N=11)

Nairobi
(%)
(N=18)

Mombasa
(%)
(N=16)

All sites
(%)
(N=36)

85.2
81.8

74.3
72.3

84.4
55.1

80.6
68.8

16.4
16.4

10.6
10.6

18.1
18.1

14.7
14.7

89.4
78.8

83.3
79.6

84.4
78.1

85.2
78.9

78.4
71.8
74.5
94.9

55.8
54.0
58.9
92.0

74.7
69.6
76.3
86.1

68.0
63.9
68.9
90.6

Provider Knowledge and Attitudes
Knowledge, attitudes and practices of facility managers are likely to influence the provision of abortion services at
health facilities. Facility in-charges were asked about the common legal grounds for procuring induced abortion in the
country and whether permission from third parties is required before performing abortion. Providers mostly cited
health reasons (64% of providers), preservation of life (43% of providers), and low socio-economic status of clients
(30%) as the common legal grounds for induced abortion (table 7). About a quarter (23%) of the providers noted that
induced abortion can be provided on request, which is contrary to existing laws and regulations. Slightly more than
half (55%) of the providers reported that permission from third parties (mostly from parents/ guardians or
spouses/partners) is needed before performing abortion. About half (49%) of providers whose facilities stocked
Misoprostol mentioned the correct regimen for pregnancies of various gestational ages (Table 7) while all providers
whose clinics stocked the combination of Mifepristone and Misoprostol mentioned the correct regimen (not shown).
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Table 7: Per cent distribution of facility in-charges by knowledge, attitudes and service provision practices regarding
abortion
Male
Female
Both sexes
Indicator
(%)
(%)
(%)
Knowledge of legal grounds for induced abortiona
(N=28)
(N=16)
(N=44)
On request
21.4
25.0
22.7
Low socioeconomic status
32.1
25.0
29.6
Health reasons
64.3
62.5
63.6
Rape
25.0
31.3
27.3
Incest
25.0
25.0
25.0
Preservation of woman’s life
46.4
37.5
43.2
Third party permissions required for abortionb
(N=28)
(N=16)
(N=44)
No
42.9
37.5
40.9
Yes
53.6
56.3
54.6
Don’t know
3.6
6.3
4.6
Persons whose permissions are requireda
(N=15)
(N=9)
(N=24)
Parent/guardian
66.7
66.7
66.7
Spouse/partner
66.7
77.8
70.8
Medical Commissions
13.3
11.1
12.5
More than 1 specialist/physician
20.0
0.0
12.5
Other
13.3
11.1
12.5
Correctly explained Misoprostol-only regimen for
55.0
38.5
48.5
pregnancies of different gestational ages
(N=20)
(N=13)
(N=33)
Notes:

aMultiple

responses; bPercentages may not sum to 100 due to rounding.

Service Provision Practices
About three-quarters (78%) of the providers reported that there were instances when their facilities denied abortion
clients the services. The most common reasons were because they could not afford to pay (46%), inappropriate
gestational age (34%), clients’ health status was not conducive (20%), and lack of appropriate equipment (20%; Figure
5). A significantly higher proportion of male compared to female providers reported inappropriate gestational age as
the reason for denying abortion clients the services while a significantly higher proportion of female than male
providers reported stock-outs and religious or moral concerns as reasons for denying abortion clients services (p<0.05
in each case).
Figure 5: Reasons for denying abortion clients services
11.4

Stock-out of drugs/supplies

27.3

4.2
14.3
18.2
12.5

Lack of third party permission

17.1

Religious/moral reasons

36.4

8.3
17.1
18.2
16.7

Lack of trained provider
Lack of appropriate equipment

20.0
18.2
20.8

Health status not conducive

20.0
18.2
20.8

Inappropriate gestational age

34.3

9.1

45.8

Inability to pay for services

36.4

0
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Both sexes
Notes: Number of cases: Males=24; Females=11.
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With respect to observations of client-provider interactions during consultations, the most commonly performed
elements were courteous handling of clients (74% of elements performed) and provision of pre-abortion information
(60% of elements performed; Table 8). The least provided services were providing recommendations following medical
examination of clients (17% of elements performed), counselling on family planning (40% of elements performed),
and conducting medical examination (45% of elements performed). In all cases, the performance of the elements was
highest in Kisumu and lowest in Nairobi (Table 8).
Table 8: Indicators of quality of abortion services in private clinics
Kisumu
%
(N=62)
61.4
81.4
71.4
49.4
46.8
51.1
25.5
61.3
62.3
87.8

Indicator
History taking (14 items)
Courteous handling of clients (11 items)
Provision of pre-abortion information (8 items)
Medical examination (15 items)
Oral examination (6 items)
Physical examination (9 items)
Post-examination recommendations (10 items)
Post-abortion care counselling (6 items)
Counselling on family planning (5 items)
Overall quality of care (69 items)

Nairobi
%
(N=58)
51.5
65.3
48.7
40.3
35.9
43.3
9.1
38.5
18.3
62.4

Mombasa
%
(N=21)
59.2
78.8
57.7
43.2
56.3
34.4
12.4
55.6
34.3
74.6

All sites
%
(N=141)
57.0
74.4
60.0
44.7
43.7
45.4
16.8
51.1
40.0
75.4

Further analysis showed that providers recommended MVA to clients in 57% of the consultations, Misoprostol alone
in 30% of the consultations, and combination of Mifepristone and Misoprostol in 9% of the consultations (not shown).
Distribution by gestational age showed that providers recommended MVA for 54% of pregnancies of up to 9 weeks,
59% of pregnancies above 9 and below 12 weeks, 31% of pregnancies between 12 and 14 weeks, and 58% of
pregnancies over 14 weeks (not shown). In addition, providers recommended the correct regimen for gestational age
in only 31% of consultations in which medical abortion (Misoprostol alone or combination of Mifepristone and
Misoprostol) was recommended. For 43 consultations in which Misoprostol alone was recommended, providers
explained the mode of action in 88% of the cases, and for the 12 consultations where combination of Mifepristone
and Misoprostol was recommended, providers explained the mode of action in 11 cases (not shown).
Almost all clients (93%) were given post-abortion care medication with the highest in Nairobi and lowest in Mombasa
(Figure 6). Although 98% of facilities indicated that they provided family planning information or methods (Table 5),
clients were counselled on family planning in 79% of the consultations and offered family planning methods in only
48% of consultations, with wide variations between study sites. Few clients were referred to another facility for further
help (13% of consultations).
Figure 6: Distribution of consultations by provision of specific abortion-related services
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Notes: Number of cases: Kisumu=62; Nairobi=58; Mombasa=21.
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Characteristics of Clients Seeking Abortion Services
The majority of clients who were observed during consultation and interviewed upon exit were aged between 20 and
29 years (66%; Table 9). Whereas more than half of the clients in Kisumu (54%) and Mombasa (52%) had primary
level education or lower, the majority in Nairobi (64%) had college-level education. Nearly three-quarters (73%) of the
clients in Kisumu were from the two poorest wealth quintiles, 57% of clients in Nairobi were from the two richest
wealth quintiles, and a similar proportion of clients in Mombasa were from the middle and richer quintiles. Many
clients (59%) were never married although there were significant differences between study sites, with the majority of
clients in Mombasa (43%) being formerly married (separated, divorced or widowed). More than half (56%) of the clients
had been pregnant more than once (Table 6) while 54% had not given birth. Among those who had given birth, 53%
had two or more living children. Sixty per cent of the clients had intention to have children in future while the majority
(78%) desired fewer than 5 children.
Table 9: Background characteristics of clients seeking abortion services

Characteristics
Age group
<20 years
20-29 years
30 years and above
Highest education level
Primary or lower
Secondary
College/university
Marital status
Never married
Married/living together
Formerly marrieda
Religious affiliation
Catholic
Protestant/other Christian
Muslim/no religion
Household wealth index
Poorest quintile
Poorer quintile
Middle quintile
Richer quintile
Richest quintile
Number of times pregnant
Once
More than once
Children ever born
0
1
2 and above
Number of living childrenb
0
1
2 and above
Intention to have children in future
No
Yes
Don’t know/up to God
Number of desired children
1-2
3-4
5 and above
Don’t know/up to God
Notes:

aSeparated/divorced/widowed; bAmong

between study sites.
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Kisumu
%
(N=48)

Nairobi
%
(N=56)

Mombasa
%
(N=21)

All sites
%
(N=125)

16.7
62.5
20.8

10.7
69.6
19.6

19.1
61.9
19.1

14.4
65.6
20.0

54.2
33.3
12.5

14.3
21.4
64.3

52.4
42.9
4.8

36.0
29.6
34.4

60.4
29.2
10.4

66.1
28.6
5.4

38.1
19.1
42.9

59.2
27.2
13.6

35.4
64.6
0.0

32.1
57.1
10.7

9.5
61.9
28.6

29.6
60.8
9.6

39.6
33.3
14.6
8.3
4.2

5.4
10.7
26.8
26.8
30.4

19.1
19.1
23.8
33.3
4.8

20.8
20.8
21.6
21.6
15.2

45.8
54.2

44.6
55.4

38.1
61.9

44.0
56.0

54.2
16.7
29.2

55.4
19.6
25.0

47.6
33.3
19.1

53.6
20.8
25.6

4.8
38.1
57.a

8.0
36.0
56.0

0.0
63.6
36.4

5.3
42.1
52.6

25.0
66.7
8.3

28.6
48.2
23.2

14.3
76.2
9.5

24.8
60.0
15.2

47.9
45.8
4.2
2.1

30.4
32.1
3.6
33.9

19.1
61.9
14.3
4.8

35.2
42.4
5.6
16.8

p=0.86

p<0.01

p<0.01

p<0.01

p<0.01

p=0.83
p=0.59

p=0.53

p=0.09

p<0.01

those who had ever given birth; p-values are from Chi-square tests of differences

Clients’ Experiences and Need for Abortion Services
Clients who had been pregnant more than once were asked about their previous experiences with miscarriages, still
births and abortions. Twenty per cent of them reported having a previous miscarriage or still birth with a significantly
lower proportion of clients in Kisumu (4%) compared to those in Nairobi (26%) and Mombasa (39%) reporting such
experiences (Table 10). The majority (86%) who had more than one pregnancy reported having a previous abortion,
with significant differences between study sites.
During consultations, observers noted whether the provider asked clients the reasons for wanting to terminate the
pregnancy, and if so, the explanations that clients gave. Providers asked for such reasons in 83% of the consultations.
The most commonly given reasons were that the pregnancy was unplanned (73%), the need to continue with education
(24%), family pressure (14%), and the need to continue with employment (14%; Table 10). Interestingly, only two
percent of pregnancies were a result of family planning method failure (not shown).
Observers further noted whether the provider established and recorded the gestational age of the pregnancy.
Providers established the gestational age of the pregnancy in 90% of the consultations with more than half (59%) of
clients seeking abortion services at 9 weeks and below while 10% sought services at more than 14 weeks of pregnancy
(Table 10).
Table 10: Per cent distribution of clients seeking abortion services by previous experiences, rationale for and
gestational age at the time of seeking care
Kisumu
Nairobi
Mombasa
All sites
Indicator
(%)
(%)
(%)
(%)
Any previous miscarriages or still birthsa
(N=26)
(N=31)
(N=13)*
(N=70)
No
96.2
74.2
61.5
80.0
Yes
3.9
25.8
38.5
20.0
Number of previous abortionsa
(N=26)
(N=31)
(N=13)**
(N=70)
0
34.6
3.2
0.0
14.3
1
53.9
61.3
76.9
61.4
2 or more
11.5
35.5
23.1
24.3
Reasons for seeking servicesb
(N=53)
(N=46)
(N=17)
(N=116)
Education/school
37.7
10.9
17.7**
24.1
Health reasons
13.2
10.9
0.0
10.3
Family pressure
26.4
2.2
5.9**
13.8
Employment-related
13.2
13.0
17.7
13.8
Unplanned/not ready for child
64.2
82.6
76.5
73.3
Gestational age at time of seeking carec
(N=49)
(N=58)
(N=19)*
(N=126)
9 weeks and below
53.1
69.0
42.1
58.7
Above 9 and below 12 weeks
22.5
22.4
15.8
21.4
Between 12-14 weeks
14.3
5.2
15.8
10.3
Over 14 weeks
10.2
3.5
26.3
9.5
Notes:

aAmong

those with two or more pregnancies; bBased on observations of client-provider interactions for consultations where
the provider asked for reasons for wanting to terminate pregnancy; cBased on observations of client-provider interactions
for consultations where the provider determined the gestational age of pregnancy; Differences between study sites are
statistically significant at: *p<0.05; **p<0.01.

Clients’ Knowledge and Use of Family Planning
Clients seeking abortion services were asked about their knowledge and prior use of family planning methods. Ninety
eight per cent of the clients reported knowing a family planning method with no significant differences between study
sites. The majority (78%) reported having ever used a family planning method with no significant differences between
study sites. The most common methods clients had ever used were male condom, oral pills, injectables, and
emergency pill (Figure 7).
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Figure 7: Per cent distribution of clients who had ever used a family planning method by type of method
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Notes: IUCD: Intra-uterine contraceptive device; Number of cases=97.

Eighty percent of the clients who had ever used family planning obtained a method themselves or together with their
partners the last time, while 19% reported that their partners obtained the method. Among clients who obtained a
method by themselves or together with their partners, 36% got it from private pharmacies, 35% from private health
facilities, and 22% from public health facilities (Figure 8).
Figure 8: Distribution of clients by source of family planning method
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Upon exit, clients were asked whether they decided to use a family planning method and if so, which method. Nearly
two-thirds (63%) chose a family planning method, most commonly injectables (40%), male condoms (33%), pills (20%),
implants (18%), and IUCDs (18%). Eleven per cent of these clients had not previously used family planning while
among those who had previously used a method, 60% chose a different method. Figure 9 shows a dramatic decline
in the use of oral pills and increases in the use of injectables, IUCD and implants among clients who had previously
used a method.
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Figure 9: Distribution of clients by type of family planning method ever used and method accepted among those who accepted a
different method from that previously used
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IUCD: Intra-uterine contraceptive device.

Clients’ Perceptions of Services Received
In all study sites, clients highly rated the consultation process with 96% of the elements reported as having been
performed by the providers (Figure 10). By contrast, providing information on the services being given was the least
rated component of the interactions with clients reporting only 58% of the elements being performed by the providers.
Overall ratings of the consultation process and information provided were highest in Kisumu and lowest in Nairobi
while rating for history taking and medical examination was highest in Kisumu and lowest in Mombasa (Figure 10).
Figure 10: Indicators of client perceptions about services received
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Clients were asked upon exit how long they waited before being seen by the provider from the time they arrived at the
facility, and whether they felt that it was reasonable. Most clients (88%) reported that the waiting time was reasonable
with no significant differences between study sites. The average waiting time was 13 minutes (9 minutes in Kisumu,
16 minutes in Nairobi, and 17 minutes in Mombasa). Most (45%) clients waited between 10 and 29 minutes (Figure
11) with wide variations between study sites.
Figure 11: Per cent distribution of clients interviewed upon exit by waiting time before being seen by the provider
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Prices of Abortion Services
Facility in-charges were asked about the prices of surgical and medical abortion services available at the clinics. The
median cost of MVA was KSh. 3,000 (≈US $35) while that of dilatation and evacuation or dilatation and curettage was
KSh. 5,000 (≈US $58; Table 11). The median price of the Misoprostol only regimen increased with higher gestation
age of pregnancy while the median price for the combination of Mifepristone and Misoprostol for pregnancies of up
to 9 weeks was KSh. 5,000 (≈US $58). There were wide variations in the prices facilities charge for the methods (Table
11). One provider reported the price of KSh. 5,000 (≈US $58) for combination of Mifepristone and Misoprostol for
pregnancies of gestational age of above 9 and below 12 weeks.
Clients were asked upon exit how much they paid for additional elements of abortion service, including transport,
consultation card, laboratory tests, other medication, counselling, and family planning methods. The results in Table
11 show that clients’ expenses on surgical abortion methods (MVA or dilatation and evacuation were quite high. In
addition, consultation fee was, on average, higher than the cost of medication.
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Table 11: Minimum, maximum and median prices of services in private clinics
Minimum
(KSH)

Services
Cost of surgical abortion methods
Manual vacuum aspiration
Dilatation and evacuation
Dilatation and curettage
Cost of Misoprostol regimen
9 weeks and below
Above 9 and below 12 weeks
Between 12-14 weeks
Cost of combination of Mife and Miso
9 weeks and below
Above 9 and below 12 weeksa

Maximum
Median
(KSH)
(KSH)
Prices given by clinics

1,500
3.500
3,500

10,500
15,000
10,000

3,000
5,000
5,000

35
7
6

360
180
90

5,000
5,000
7,000

2,500
3,000
4,500

16
10
6

1,000
--

7,000

5,000
--

5
1

70
2,000
50
200
1,400
100
4,000
4,250
9,000

67
73
17
25
22
10
18
2
2

Expenses incurred by clients
Client expenses on
Transport
Consultation
Card
Laboratory tests
Medication
Family planning method(s)
Manual vacuum aspiration
Miso and manual vacuum aspiration
Dilatation and evacuation
Notes:

aOne

Number of
clinics

10
100
50
99
200
50
300
3,500
8,000

800
5,400
8,500
400
6,500
3,500
7,000
5,000
10,000

provider reported KSh. 5,000; KSH: Kenya shilling (1 USD ≈ KSH. 85).

SUMMARY AND IMPLICATIONS
Summary of Findings


The most common aspects related to the provision of abortion services that private providers had received inservice training on were infection prevention (78% of facilities), referral procedures (76% of facilities); and
managing complications (76% of facilities) while the least aspects were the national standards and guidelines
(60% of facilities) and the legal and policy provisions regarding abortion (51% of facilities).



Availability of drugs and supplies for medical abortion was very limited (15% of items) although the proportion of
items that were in stock on the day of interview was similar to what were reported to be available. By contrast,
facilities had most of the drugs and supplies for surgical abortion (81% of items) as well as for recovery, pain
management and treatment of complications (85% of items) although the proportions of items that were in stock
on the day of interview were lower than what was reported to be available.



Although providers mostly cited health reasons (64% of providers) and preservation of the mother’s life (43% of
providers) as the common legal grounds for induced abortion, about a quarter (23%) noted that induced abortion
can be provided on request, which is contrary to existing laws and regulations. In addition, only about half (49%)
of providers whose facilities stocked Misoprostol mentioned the correct regimen for pregnancies of various
gestational ages.



Two-thirds (66%) of the women seeking abortion services from private clinics were aged between 20 and 29 years,
64% had at least secondary level education, 59% were never married while 56% had a previous pregnancy, with
the majority of those who had more than one pregnancy (86%) reporting having a previous abortion.



More than half (59%) of clients seeking abortion services had pregnancies of up to 9 weeks with the most common
reason for seeking abortion services being that the pregnancy was unplanned (73%) while other reasons included
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the need to continue with education (24%), family pressure (14%), and the need to continue with employment
(14%).


Providers recommended the correct regimen for gestational age in only 31% of consultations in which medical
abortion (Misoprostol alone or combination of Mifepristone and Misoprostol) was offered. By contrast, providers
recommended manual vacuum aspiration for 54% of pregnancies of up to 9 weeks, 59% of pregnancies above 9
and below 12 weeks, 31% of pregnancies between 12 and 14 weeks, and 58% of pregnancies over 14 weeks.



Although nearly all (98%) private clinics reported providing family planning information or methods, only 79% of
the clients seeking abortion services were counselled on family planning while 48% were given a method. Besides,
elements of family planning counselling were some of the least performed functions during consultations (40% of
elements performed) while elements of interpersonal relationships such as courteous handling of clients were
some of the most performed by providers (74% of elements performed).



The majority of clients seeking abortion services (78%) had previously used a family planning method, mostly
male condom, oral pills, injectables, and emergency pill. Nearly two-thirds (63%) chose a method on the day of
visit, mostly injectables (40%), male condoms (33%), pills (20%), implants (18%), and IUCDs (18%) while 60% of
those who had a previously used a method chose a different method, mostly injectables, IUCD and implants.



Prices of medical abortion drugs increased with higher gestation age of pregnancy although there were wide
variations in the prices facilities charge for the methods, ranging from KSh. 90 (≈US $1) to KSh. 7,000 (≈US $82).
Prices of surgical abortion methods also varied widely between facilities from KSh. 1,500 (≈US $18) to KSh.
15,000 (≈US $176).

Implications


There is need for widespread dissemination of the existing policies and guidelines regarding abortion among
private providers to ensure that they offer services within existing regulations.



There is need to improve the supply chain for medical abortion drugs (especially combined Mifepristone and
Misoprostol) in private clinics.



There is need strategies to improve the capacity of private providers to offer appropriate family planning services
to clients seeking abortion, especially long-term methods given the high rate of repeat abortions.
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Study Limitations
One of the limitations of the study stems from the technique of observing clients and providers during consultations
as it is likely that providers may bias their behaviour in a positive way. To address this issue, all observers had medical
qualifications as this was expected to raise the comfort levels of the providers such that their behaviours become
normative. In addition, it was emphasized during training that at the beginning of the observation the observers should
let the providers know that they were not there to evaluate them and that the observers were not experts who could
be consulted during the session.
A second limitation was that although facilities were randomly sampled from among those that were members of RHN
or the AMUA Franchise, the clients were not randomly sampled as they were observed or interviewed upon exit based
on their expressed willingness to participate voluntarily in the study. It could be that those who accepted to participate
in the study were self-selecting based on a greater willingness to share their experiences regarding this stigmatized
behaviour and so their experiences may not be representative of all clients seeking abortion services from private
health facilities.
Another limitation stems from the unclear or ambiguous nature of the Kenyan legal status on abortion, which could
have induced study participants, especially private pharmacy workers, to deny knowledge of the subject or to provide
responses in line with the prevailing legal and socio-cultural context. In addition, given that written informed consent
was obtained from the pharmacy proprietor in advance of the simulated client visits, he/she may have instructed
employees to change their practice for the period of the study. The simulated client method itself is also prone to
certain biases especially the ability of the simulated client to appropriately enact the assigned role and to recall details
of the interaction after the event.
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Appendices
Table A1: Items used to compute composite scores for indicators of availability of services at facilities
I. PRE-ABORTION PROCESSES
1) Pre-procedure counselling
3) Medical examination
2) History taking
4) Pregnancy screening
II. PAIN MANAGEMENT PROCEDURES
1) Counselling client
3) Verbal reassurance
5) Tranquilizers
2) Listening to music
4) Analgesics
6) Anaesthetics
III. INFECTION PREVENTION/CONTROL PRACTICES
1) Hand-washing with soap and water
4) Cleaning/disinfecting medical equipment
2) Wearing protective gear
5) Safe disposal of waste
3) Routine cleaning of facility
6) Careful handling and disposal of sharps
IV. MANAGING ABORTION-RELATED COMPLICATIONS
1) Vacuum aspiration for uterine evacuation
5) Antibiotics
2) Dilatation and curettage for uterine evacuation
6) Blood transfusion
3) Misoprostol
7) Laparotomy
4) Uterotonic drugs
8) Prompt referral
V. DRUGS AND SUPPLIES FOR SURGICAL ABORTION
1) Clean examination gloves
9) Syringes (5, 10 and 20ml)
2) Heavy duty gloves
10) Lidocaine for paracervical block
3) Sterile/surgical gloves
11) Gauze sponges or cotton balls
4) Cervical preparation agents
12) STI/RTI drugs
5) Detergent or soap
13) Antiseptic solution to prepare cervix
6) Gown/face protection
14) Instrument-soaking solution
7) Needles (22 gauge spinal for para cervical block)
15) Sterilization or high-level disinfection solutions
8) Needles (21 gauge for drug administration)
16) Silicone for lubricating syringes
VI. DRUGS AND SUPPLIES FOR MEDICAL ABORTION
1) Misoclear
5) Arthrotec
9) Mediprist
2) Cytotec-pharmacia UK
6) Mifepristone Linepharma 200mg
10) Combination of Mifepristone
3) Isovent
7) Marisg
and Misoprostol
4) Daytech/Dytek
8) Mifegyne
VII. RECOVERY, PAIN AND COMPLICATIONS MANAGEMENT
1) Sanitary napkins/cotton wool
3) Tranquilizers
5) Uterotonics
2) Analgesics
4) Anaesthetics
6) Intravenous line and fluids
VIII. EQUIPMENT FOR SURGICAL/MEDICAL ABORTION
1) Blood pressure equipment
12) Large postpartum flexible curette
2) Stethoscope
13) Sponge (ring forceps)
3) Speculum (wide mouth to increase cervix exposure)
14) Stainless steel bowl for prepping solution
4) Speculum (short to avoid pushing away cervix)
15) Instrument stray
5) Tenaculum (atraumatic)
16) Clear glass dish for tissue inspection
6) Tapered dilators up to 37-51mm or equivalent
17) Long needle-driver and suture
7) Electric vacuum aspirator (14 or 16mm cannulae)
18) Scissors
8) Manual vacuum aspirator and cannulae up to 12mm
19) Oxygen and Ambu bag
9) Bierer uterine evacuation forceps (large)
20) Uterine packing
10) Bierer uterine evacuation forceps (small)
21) Strainer (metal, glass or gauze)
11) Sopher uterine evacuation forceps (small)
IX. SERVICE STANDARDS AND GUIDELINES
1) Clear policy on confidentiality of clients
4) Copy of WHO technical and policy guidance
2) Clear procedures for record-keeping/reporting
5) Clear referral mechanisms to higher level facilities
3) Copy of national standards and guidelines
X. INFRASTRUCTURE
1) Private waiting area with seats
6) Reliable lighting
2) Private space for MVA/pelvic exam
7) Client toilets
3) Source of clean water for 24 hours
8) Clean water for drinking
4) Power for fridge to remain functional 24 hours a day
9) Clean cups/glasses for drinking water
5) Working autoclave/sterilization

32

Table A2: Items used to compute composite scores for quality of abortion services
I. HISTORY TAKING
Provider asked:
6) Previous use of family planning
11) Unprotected sexual intercourse
1) Purpose of visit
7) Client discussed family planning with 12) Gender-based violence
2) Client’s age
partner
13) Allergies
3) Client’s marital status
8) Partner cooperation
14) Reasons for wanting to terminate
4) Number of sexual partners
9) History of medical conditions
pregnancy
5) Previous pregnancy history
10) STIs/HIV risk factors
II. MEDICAL EXAMINATION: ORAL
Provider discussed:
1) Date of last menstrual period
4) Previous history of ectopic pregnancy/STIs
2) Whether menstruation was normal
5) Current use of medications
3) Whether amenorrheic or using injectables
6) Experiences of violence or coercion
III. MEDICAL EXAMINATION: PHYSICAL
Provider examined/performed:
1) Pulse
4) Abdomen
7) Presence of STIs/RTIs
2) Blood pressure
5) Softening cervical isthmus
8) Mass pelvic examination
3) Temperature
6) Softening and enlarging of uterus
9) Bimanual examination
IV. POST-EXAMINATION RECOMMENDATIONS
1) Pregnancy test
5) Blood test for haemoglobin only
9) Investigating bleeding tendencies in
2) Ultrasound
6) Blood test for full haemogram
the family
3) Rhesus test
7) Ectopic pregnancy test
10) Investigating gender-based
4) HIV counselling/testing
8) Checking for history of STIs/RTIs
violence
V. POST-ABORTION CARE COUNSELLING
Provider counsels client on:
1) When to seek further care
3) When to resume sexual activity
5) Family planning
2) Self-care after leaving facility
4) Prevention of STIs/HIV
6) Any other post-abortion aspect
VI. OVERALL ASSESSMENT OF CONSULTATION
1) Provider observed infection prevention procedures
5) Provider emphasised importance of dual protection
2) Provider informed client about HIV/VCT
6) Provider gave client reminder of when to return
3) Provider conducted HIV/STI risk assessment
7) Physical infrastructure ensured client comfort
4) Provider counselled client in a supportive way
8) Physical facilities ensured audio and visual privacy
VII. CLIENT PERCEPTIONS: HISTORY TAKING/MEDICAL EXAMINATION
Provider:
6) Asked about last menstrual period
1) Asked about purpose of visit
7) Asked about duration of pregnancy
2) Asked about medical history
8) Checked blood pressure
3) Asked about age
9) Performed abdominal examination
4) Asked about marital status
10) Asked about fertility experiences and intentions
5) Asked about support from partner
11) Asked about previous use of family planning
VIII. CLIENT PERCEPTIONS: CONSULTATION PROCESS
Provider:
1) Ensured privacy
3) Showed non-judgemental attitude
2) Sought consent in a respectful manner
4) Talked in a language client understood
IX. CLIENT PERCEPTIONS: INFORMATION GIVEN
Provider gave information on:
1) What was going to be done
8) Other available options for managing the pregnancy
2) What client is likely to experience
9) Available psycho-social support services
3) How long the process would take
10) Child-spacing and family planning
4) Risks and complications associated with the process
11) STIs/HIV
5) How to manage pain
12) Whether and when to return to facility
6) What to do in case of complications
13) Written materials on services that client received
7) When client is likely to resume normal activities
14) Referral to another clinic for more services
X. CLIENT PERCEPTIONS: SATISFACTION WITH SERVICES
1) Facility is clean/tidy
6) Drugs/medicines are always available at facility
2) Waiting time before seeing provider was reasonable
7) Provider treated client with respect
3) Provider is always available at the facility
8) Confidentiality/privacy was ensured
4) Provider was responsive/understanding
9) Cost of services was reasonable
5) Provider was knowledgeable
10) Client was happy overall with services at the facility
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